StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) stock

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3034% above fair value
$104.71−2.74 (-2.55%)

Close on Nov 17, 2026Market cap $181.19BP/E 33.7Yield 2.29%

Abbott Laboratories pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Abbott Laboratories's pe ratio was 35.1× on Nov 11, 2026, against 16.1× a year earlier. Over the last 5 years it ranged from 13.7× to 38.9×, with a median of 30.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202635.1×+19.5
2025Dec 31, 202515.7×−18.7
2024Dec 31, 202434.4×−3.1
2023Dec 29, 202337.4×+12.7
2022Dec 30, 202224.8×−10.1
2021Dec 31, 202134.9×−23.0
2020Dec 31, 202057.9×+10.7
2019Dec 31, 201947.2×−103.5
2018Dec 31, 2018150.7×+105.8
2017Dec 29, 201744.9×+2.7
2016Dec 30, 201642.2×+27.2
2015Dec 31, 201515.0×−20.5
2014Dec 31, 201435.4×+15.4
2013Dec 31, 201320.1×+4.1
2012Dec 31, 201216.0×−3.4
2011Dec 30, 201119.5×+3.6
2010Dec 31, 201015.9×+1.2
2009Dec 31, 200914.7×–

More Abbott Laboratories figures

See a number that looks wrong?